Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Long-term prognosis of 69 patients with dermatomyositis or polymyositis.

Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM.

Clin Exp Rheumatol. 1996 May-Jun;14(3):263-74.

PMID:
8809440
2.

Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.

Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A.

Autoimmun Rev. 2014 Oct;13(10):1048-54. doi: 10.1016/j.autrev.2014.08.023. Epub 2014 Aug 23.

PMID:
25183232
3.

Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.

Ishizuka M, Watanabe R, Ishii T, Machiyama T, Akita K, Fujita Y, Shirota Y, Fujii H, Harigae H.

Mod Rheumatol. 2016;26(1):115-20. doi: 10.3109/14397595.2015.1054081. Epub 2015 Jun 13.

PMID:
26011440
4.

Long-term follow-up of 76 Iranian patients with idiopathic inflammatory myopathies.

Hajialilo M, Ghorbanihaghjo A, Khabbazi A, Kolahi S, Jafari Nakhjavani MR, Ebrahimi AA, Zareh H, Malek Mahdavi A.

Int J Rheum Dis. 2018 Aug;21(8):1627-1633. doi: 10.1111/1756-185X.13352.

PMID:
30146744
5.

Long-term outcome in polymyositis and dermatomyositis.

Bronner IM, van der Meulen MF, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, Hoogendijk JE.

Ann Rheum Dis. 2006 Nov;65(11):1456-61. Epub 2006 Apr 10.

6.

Prognosis and mortality of polymyositis and dermatomyositis patients.

Airio A, Kautiainen H, Hakala M.

Clin Rheumatol. 2006 Mar;25(2):234-9. Epub 2006 Feb 14.

PMID:
16477398
7.

Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.

Santo AH, Souza JM, Pinheiro CE, Souza DC, Sato EI.

BMC Public Health. 2010 Oct 11;10:597. doi: 10.1186/1471-2458-10-597.

8.

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality.

Sultan SM, Ioannou Y, Moss K, Isenberg DA.

Rheumatology (Oxford). 2002 Jan;41(1):22-6.

PMID:
11792875
9.

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases.

Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G.

Medicine (Baltimore). 2004 Jan;83(1):35-42.

10.

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, Courtois H.

J Rheumatol. 2001 Oct;28(10):2230-7.

PMID:
11669162
11.

Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.

Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF.

Arthritis Rheum. 2011 Nov;63(11):3439-47. doi: 10.1002/art.30513.

12.

Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.

Wakata N, Kurihara T, Saito E, Kinoshita M.

Int J Dermatol. 2002 Nov;41(11):729-34.

PMID:
12452993
13.

[The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].

Wang PZ, Guan JL, Han XH.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Jun;31(6):417-20. Chinese.

PMID:
19031800
14.

Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.

Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.

PLoS One. 2015 Mar 19;10(3):e0120313. doi: 10.1371/journal.pone.0120313. eCollection 2015.

15.
16.

Survival of patients with polymyositis/dermatomyositis and pulmonary involvement.

Miró O, Laguno M, Grau JM.

J Rheumatol. 1999 Aug;26(8):1852-4. No abstract available.

PMID:
10451094
17.

Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.

Yu KH, Wu YJ, Kuo CF, See LC, Shen YM, Chang HC, Luo SF, Ho HH, Chen IJ.

Clin Rheumatol. 2011 Dec;30(12):1595-601. doi: 10.1007/s10067-011-1840-0. Epub 2011 Sep 14.

PMID:
21915609
18.

Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study.

Maldonado F, Patel RR, Iyer VN, Yi ES, Ryu JH.

Respirology. 2012 Apr;17(3):455-60. doi: 10.1111/j.1440-1843.2011.02103.x.

PMID:
22085242
19.

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.

Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC.

Arthritis Res Ther. 2012 Jan 27;14(1):R22. doi: 10.1186/ar3704.

20.

Pulmonary involvement in polymyositis and in dermatomyositis.

Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B.

J Rheumatol. 1998 Jul;25(7):1336-43.

PMID:
9676766

Supplemental Content

Support Center